BACKGROUND: We studied anomalous extracellular mRNAs in plasma from patients with diffuse large B-cell lymphoma (DLBCL) and their survival implications. mRNAs studied have been reported in the literature as markers of poor (BCL2. CCND2. MYC) and favorable outcome (LMO2. https://www.jmannino.com/super-save-NFL-Chicago-Bears-Blast-iPhone-14-Plus-Skin-p41373-big-savings/